IN VITRO METHOD FOR THE PROGNOSIS OF PATIENTS SUFFERING FROM SEPSIS

The present invention refers to an in vitro method for the prognosis of patients suffering from sepsis, preferably COVID-19 patients. In a preferred embodiment, a bad prognosis means that the patient has an increased risk of developing Acute respiratory distress syndrome (ARDS). La présente inventio...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	FUENTES GARCÍA, Manuel, LORENTE BALANZA, José Ángel, FERRUELO ALONSO, Antonio, LANDEIRA VIÑUELA, Alicia, HERRERO HERNÁNDEZ, Raquel, HERNÁNDEZ, Ángela Patricia, JUANES VELASCO, Pablo
Format:	Patent
Sprache:	eng ; fre
Schlagworte:	INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The present invention refers to an in vitro method for the prognosis of patients suffering from sepsis, preferably COVID-19 patients. In a preferred embodiment, a bad prognosis means that the patient has an increased risk of developing Acute respiratory distress syndrome (ARDS). La présente invention concerne un procédé in vitro pour le pronostic de patients atteints de sepsis, de préférence de patients atteints de COVID-19. Dans un mode de réalisation préféré, un mauvais pronostic signifie que le patient a un risque accru de développer un syndrome de détresse respiratoire aiguë (SDRA).